$966 Million is the total value of Soleus Capital Management, L.P.'s 77 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 128.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRcall | $158,516,800 | – | 2,080,000 | +100.0% | 16.42% | – |
| EDAP | Buy | EDAP TMS S Asponsored adr | $58,806,298 | +7.4% | 5,312,222 | +3.5% | 6.09% | -22.4% |
| ISEE | Buy | IVERIC BIO INC | $51,750,956 | +14.3% | 2,127,043 | +0.6% | 5.36% | -17.5% |
| Buy | ARCELLX INC | $38,455,409 | +12.6% | 1,248,147 | +13.2% | 3.98% | -18.7% | |
| CRL | Buy | CHARLES RIV LABS INTL INC | $31,503,295 | +42.0% | 156,096 | +53.3% | 3.26% | +2.4% |
| EXAS | Buy | EXACT SCIENCES CORP | $30,955,265 | +117.6% | 456,500 | +58.9% | 3.21% | +57.1% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $30,511,191 | -14.5% | 136,235 | +6.2% | 3.16% | -38.2% |
| IRMD | Buy | IRADIMED CORP | $30,444,859 | +44.5% | 773,694 | +3.9% | 3.15% | +4.3% |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $27,078,282 | – | 970,200 | +100.0% | 2.80% | – |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $20,987,024 | +6.0% | 9,853,063 | +33.8% | 2.17% | -23.5% |
| SIBN | New | SI-BONE INC | $20,869,536 | – | 1,060,983 | +100.0% | 2.16% | – |
| SRDX | Buy | SURMODICS INC | $20,335,205 | -23.1% | 892,678 | +15.1% | 2.11% | -44.5% |
| CVS | Buy | CVS HEALTH CORP | $18,098,498 | +105.0% | 243,554 | +157.0% | 1.87% | +47.9% |
| CELC | Buy | CELCUITY INC | $17,301,313 | +2.0% | 1,687,933 | +39.5% | 1.79% | -26.3% |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $16,899,980 | – | 12,803,015 | +100.0% | 1.75% | – |
| AXGN | Buy | AXOGEN INC | $16,820,981 | +122.9% | 1,779,998 | +135.5% | 1.74% | +61.0% |
| NTRA | New | NATERA INC | $16,333,984 | – | 294,200 | +100.0% | 1.69% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $15,873,905 | – | 174,592 | +100.0% | 1.64% | – |
| SGEN | New | SEAGEN INC | $14,375,370 | – | 71,000 | +100.0% | 1.49% | – |
| New | JASPER THERAPEUTICS INC | $13,493,514 | – | 7,454,980 | +100.0% | 1.40% | – | |
| EPIX | Buy | ESSA PHARMA INC | $12,310,997 | +26.3% | 4,145,117 | +7.1% | 1.28% | -8.9% |
| BCAB | Buy | BIOATLA INC | $11,580,808 | -66.7% | 4,321,197 | +2.4% | 1.20% | -76.0% |
| TGTX | Buy | TG THERAPEUTICS INC | $11,284,512 | +300.8% | 750,300 | +215.3% | 1.17% | +189.4% |
| NPCE | Buy | NEUROPACE INC | $11,269,233 | +219.3% | 2,428,714 | +2.5% | 1.17% | +130.6% |
| LNTH | New | LANTHEUS HLDGS INC | $9,387,072 | – | 113,700 | +100.0% | 0.97% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $8,858,137 | – | 1,449,777 | +100.0% | 0.92% | – |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $8,758,986 | +14.5% | 411,800 | +59.4% | 0.91% | -17.3% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $8,068,986 | +42.6% | 469,400 | +84.3% | 0.84% | +3.0% |
| NVCR | New | NOVOCURE LTD | $7,818,200 | – | 130,000 | +100.0% | 0.81% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $7,659,000 | – | 460,000 | +100.0% | 0.79% | – |
| ETNB | Buy | 89BIO INC | $7,523,620 | +55.9% | 494,000 | +30.3% | 0.78% | +12.6% |
| THTX | Buy | THERATECHNOLOGIES INC | $7,363,314 | -5.2% | 9,090,511 | +3.3% | 0.76% | -31.5% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,813,312 | +21.7% | 322,600 | +46.6% | 0.71% | -12.1% |
| New | GENEDX HOLDINGS CORP | $6,548,100 | – | 17,940,000 | +100.0% | 0.68% | – | |
| ALKS | New | ALKERMES PLC | $6,483,700 | – | 230,000 | +100.0% | 0.67% | – |
| New | NUVALENT INC | $6,180,721 | – | 236,900 | +100.0% | 0.64% | – | |
| KRTX | New | KARUNA THERAPEUTICS INC | $6,128,534 | – | 33,740 | +100.0% | 0.64% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $6,035,120 | – | 364,000 | +100.0% | 0.62% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $5,812,840 | – | 242,000 | +100.0% | 0.60% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $5,276,154 | – | 234,600 | +100.0% | 0.55% | – |
| New | MINERALYS THERAPEUTICS INC | $4,278,954 | – | 273,241 | +100.0% | 0.44% | – | |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $4,035,631 | +288.0% | 4,134,868 | +313.5% | 0.42% | +180.5% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $3,780,450 | – | 155,000 | +100.0% | 0.39% | – |
| ABCM | New | ABCAM PLCads | $3,768,410 | – | 279,971 | +100.0% | 0.39% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $3,575,800 | – | 190,000 | +100.0% | 0.37% | – |
| ANNX | New | ANNEXON INC | $3,524,290 | – | 915,400 | +100.0% | 0.36% | – |
| New | PARAGON 28 INC | $3,482,587 | – | 204,018 | +100.0% | 0.36% | – | |
| PHVS | Buy | PHARVARIS N V | $2,713,730 | -22.2% | 336,900 | +8.7% | 0.28% | -43.8% |
| FGEN | Buy | FIBROGEN INC | $2,415,780 | +32.9% | 129,463 | +14.1% | 0.25% | -4.2% |
| ANGO | New | ANGIODYNAMICS INC | $2,326,500 | – | 225,000 | +100.0% | 0.24% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $2,014,410 | – | 249,000 | +100.0% | 0.21% | – |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $1,893,572 | – | 95,346 | +100.0% | 0.20% | – |
| Buy | AMYLYX PHARMACEUTICALS INC | $1,854,699 | -0.9% | 63,214 | +24.8% | 0.19% | -28.4% | |
| New | RXSIGHT INC | $1,334,400 | – | 80,000 | +100.0% | 0.14% | – | |
| New | ORCHESTRA BIOMED HLDGS INC | $1,183,007 | – | 60,450 | +100.0% | 0.12% | – | |
| IMUX | New | IMMUNIC INC | $447,000 | – | 300,000 | +100.0% | 0.05% | – |
| New | MDXHEALTH SAsponsored ads | $194,400 | – | 60,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.